CGC
NYSECanopy Growth Corporation
SectorHealth CareIndustry Medicinal Chemicals and Botanical Products
Price$1.07+0.00 (+0.00%)
01:30 PM07:45 PM
News · 26 weeks47+233%
2026-03-012026-08-23
Mix3290d
- SEC Filings12(38%)
- Insider11(34%)
- Other5(16%)
- Earnings3(9%)
- Leadership1(3%)
Latest news
25 items- SECSEC Form DEFA14A filed by Canopy Growth CorporationDEFA14A - Canopy Growth Corp (0001737927) (Filer)
- PRCanopy Growth Announces Mailing of Proxy Materials for 2026 Annual General and Special Meeting – Urges Shareholders to Vote NowShareholders are encouraged to vote well in advance of the meeting scheduled on September 25, 2026, at 1:00 PM ET. To ensure that votes are counted, Shareholders must submit their vote no later than 1:00 p.m. ET on September 23, 2026. Canopy Growth shareholders with a 16-digit control number can vote at http://proxyvote.com, or by phone at 1-800-474-7493 (English) or 1-800-474-7501 (French). Many shareholders are also eligible to vote quickly and conveniently over the phone by contacting the Company’s proxy solicitation agent, Sodali & Co. at 1-833-830-8205 toll free in North America or 1-289-695-3075 collect outside North America or by email at CGC@investor.sodali.com Canopy Growth C
- SECSEC Form DEFA14A filed by Canopy Growth CorporationDEFA14A - Canopy Growth Corp (0001737927) (Filer)
- PRCanopy Growth Secures Renewed EU GMP Certification at Kincardine as European Medical Cannabis Business GrowsRenewed certification maintains Kincardine’s role in Canopy Growth’s EU GMP flower supply chain Canopy Growth Corporation ("Canopy Growth", "our", "we" or the "Company") (TSX:WEED) (NASDAQ:CGC), a leading global company committed to bettering lives through cannabis, today announced that its Kincardine, Ontario cultivation facility ("Kincardine") has received renewed European Union Good Manufacturing Practice ("EU GMP") certification from the Regierungspräsidium Tübingen – Leitstelle Arzneimittelüberwachung Baden-Württemberg. With its EU GMP status renewed, Canopy Growth can continue supplying Canadian-grown cannabis from Kincardine to medical cannabis markets across Europe. "This rene
- SECSEC Form DEFA14A filed by Canopy Growth CorporationDEFA14A - Canopy Growth Corp (0001737927) (Filer)
- SECSEC Form DEF 14A filed by Canopy Growth CorporationDEF 14A - Canopy Growth Corp (0001737927) (Filer)
- SECCanopy Growth Corporation filed SEC Form 8-K: Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits8-K - Canopy Growth Corp (0001737927) (Filer)
- SECCanopy Growth Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - Canopy Growth Corp (0001737927) (Filer)
- PRCanopy Growth Reports First Quarter Fiscal Year 2027 Financial Results; Delivers 13% Net Revenue Growth with Contributions from All BusinessesNet revenue growth of 22% in Canada medical cannabis, 10% in Canada adult-use cannabis, 10% in international markets cannabis and 6% in Storz & Bickel Adjusted gross margin1 improves to 31% in Q1 FY2027 from 25% in Q1 FY2026 Adjusted EBITDA2 loss narrows by 59% year-over-year Canopy Growth Corporation ("Canopy Growth", "our", "we" or the "Company") (TSX:WEED) (NASDAQ:CGC), a leading global company committed to bettering lives through cannabis, today announced its financial results for the three months ended June 30, 2026 ("Q1 FY2027"). All financial information in this press release is reported in Canadian dollars, unless otherwise indicated. "The renewed focus and strong momentum w
- SECSEC Form 10-Q filed by Canopy Growth Corporation10-Q - Canopy Growth Corp (0001737927) (Filer)
- PRCanopy Growth to Report First Quarter Fiscal 2027 Financial Results on August 7, 2026Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX:WEED) (NASDAQ:CGC) will release its financial results for the first quarter fiscal year 2027 ended June 30, 2026 before financial markets open on August 7, 2026. Following the release of its financial results, Canopy Growth will host an audio webcast with Luc Mongeau, CEO, and Tom Stewart, CFO, on August 7, 2026 at 10:00 AM Eastern Time (ET). A live audio webcast will be available at: https://onlinexperiences.com/Launch/QReg/ShowUUID=567345EB-EB0A-41BF-ABD6-785F173BBEFE A replay will be accessible by webcast until 11:59 PM ET on November 5, 2026 at the same URL. About Canopy Growth Canopy Growth is a world-leading c
- PRCanopy Growth Announces Participation at Upcoming Canaccord Genuity Growth ConferenceCanopy Growth Corporation ("Canopy Growth" or the "Company") (TSX:WEED) (NASDAQ:CGC) announced it will be participating at the Canaccord Genuity Growth Conference in August 2026. Canopy Growth CEO Luc Mongeau will be presenting on Tuesday, August 11 at 12:00 p.m. The presentation will be publicly accessible via live webcast at https://event.summitcast.com/view/WuFmFdTcA9mVsUGHZJFU62/8jLaQ2EHsfTiWktFQKVomw, and archived for 180 days. Canaccord Genuity's 46th Annual Growth Conference is set to take place in Boston, MA from August 11-13, 2026 and aims to bring together institutional investors from across the globe with some of the best and most promising growth companies in the Technology,
- SECSEC Form PRE 14A filed by Canopy Growth CorporationPRE 14A - Canopy Growth Corp (0001737927) (Filer)
- INSIDERDirector Bayern Joseph sold $2,953 worth of shares (3,197 units at $0.92), decreasing direct ownership by 2% to 145,127 units (SEC Form 4) (withholding tax)4 - Canopy Growth Corp (0001737927) (Issuer)
- INSIDERDirector Yanofsky Theresa sold $13,905 worth of shares (15,054 units at $0.92), decreasing direct ownership by 9% to 146,415 units (SEC Form 4) (withholding obligation)4 - Canopy Growth Corp (0001737927) (Issuer)
- INSIDERDirector Atkins M Shan sold $2,953 worth of shares (3,197 units at $0.92), decreasing direct ownership by 2% to 146,517 units (SEC Form 4) to cover taxes4 - Canopy Growth Corp (0001737927) (Issuer)
- INSIDERDirector Lazzarato David Angelo sold $20,944 worth of shares (22,674 units at $0.92), decreasing direct ownership by 10% to 211,859 units (SEC Form 4) to cover withholding tax4 - Canopy Growth Corp (0001737927) (Issuer)
- INSIDERDirector Atkins M Shan was granted 108,324 shares, increasing direct ownership by 262% to 149,714 units (SEC Form 4)4 - Canopy Growth Corp (0001737927) (Issuer)
- INSIDERDirector Lazzarato David Angelo was granted 162,485 shares, increasing direct ownership by 226% to 234,533 units (SEC Form 4)4 - Canopy Growth Corp (0001737927) (Issuer)
- INSIDERDirector Bayern Joseph was granted 108,324 shares, increasing direct ownership by 271% to 148,324 units (SEC Form 4)4 - Canopy Growth Corp (0001737927) (Issuer)
- INSIDERDirector Yanofsky Theresa was granted 108,324 shares, increasing direct ownership by 204% to 161,469 units (SEC Form 4)4 - Canopy Growth Corp (0001737927) (Issuer)
- INSIDEROfficer Stewart Thomas Carlton was granted 379,018 shares and sold $9,045 worth of shares (9,285 units at $0.97), increasing direct ownership by 150% to 616,398 units (SEC Form 4) to satisfy withholding tax4 - Canopy Growth Corp (0001737927) (Issuer)
- INSIDEROfficer Gedeon Christelle was granted 396,012 shares and sold $57,466 worth of shares (58,994 units at $0.97), increasing direct ownership by 91% to 705,506 units (SEC Form 4) to satisfy withholding tax4 - Canopy Growth Corp (0001737927) (Issuer)
- INSIDERChief Executive Officer Mongeau Luc was granted 1,056,152 shares and sold $131,729 worth of shares (135,231 units at $0.97), increasing direct ownership by 115% to 1,723,913 units (SEC Form 4) (tax liability)4 - Canopy Growth Corp (0001737927) (Issuer)
- SECSEC Form S-8 filed by Canopy Growth CorporationS-8 - Canopy Growth Corp (0001737927) (Filer)
CGC FAQ
6 questionsWhat does Canopy Growth Corporation do?
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include dried cannabis flowers, oils and concentrates, and softgel capsules. It offers its products under the Tweed, Quatreau, Deep Space, Spectrum Therapeutics, First & Free, TWD, This Works, BioSteel, DNA Genetics CraftGrow, Tokyo Smoke, DOJA, Van der Pop...Where does CGC stock trade?
Canopy Growth Corporation (CGC) is listed on NYSE.What sector and industry is CGC in?
Canopy Growth Corporation operates in the Health Care sector, Medicinal Chemicals and Botanical Products industry.What are analysts saying about CGC?
Canopy Growth Corporation has had 8 recent analyst actions on file. The most recent action was from Canaccord Genuity: Buy on 2026-03-27.What companies are similar to CGC?
Notable peers in the same industry include PM (Philip Morris International Inc), BTI (British American Tobacco Industries p.l.c.), MO (Altria Group Inc.), DFTX (Definium Therapeutics Inc.), RLX (RLX Technology Inc.). Compare CGC side-by-side with any of them on Quantisnow.How can I track CGC on Quantisnow?
Quantisnow aggregates Canopy Growth Corporation's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow CGC to receive live email and push alerts on every new disclosure.